These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33367961)

  • 41. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance.
    Zhang L; Beal SL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):387-404. PubMed ID: 15000421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population pharmacodynamics of cilostazol in healthy Korean subjects.
    Jung YS; Chae D; Park K
    Transl Clin Pharmacol; 2018 Jun; 26(2):93-98. PubMed ID: 32055555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.
    Abrantes JA; Jönsson S; Karlsson MO; Nielsen EI
    Br J Clin Pharmacol; 2019 Jun; 85(6):1326-1336. PubMed ID: 30767254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting Antitumor Effect of Deoxypodophyllotoxin in NCI-H460 Tumor-Bearing Mice on the Basis of In Vitro Pharmacodynamics and a Physiologically Based Pharmacokinetic-Pharmacodynamic Model.
    Chen Y; Zhao K; Liu F; Li Y; Zhong Z; Hong S; Liu X; Liu L
    Drug Metab Dispos; 2018 Jun; 46(6):897-907. PubMed ID: 29618575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations.
    Ozdin D; Sharma N; Lujan-Zilbermann J; Colucci P; Kanfer I; Ducharme MP
    J Pharm Pharm Sci; 2018; 21(1):413-428. PubMed ID: 30407906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.
    Lötsch J; Skarke C; Schmidt H; Grösch S; Geisslinger G
    Anesthesiology; 2001 Dec; 95(6):1329-38. PubMed ID: 11748388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of etanercept dose reduction in patients with rheumatoid arthritis using pharmacokinetic/pharmacodynamic modeling and simulation.
    Hsu LF; Huang JD
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):776-86. PubMed ID: 24887337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.
    Thomas N
    J Biopharm Stat; 2006; 16(5):657-77. PubMed ID: 17037264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect.
    Millenbaugh NJ; Wientjes MG; Au JL
    Cancer Chemother Pharmacol; 2000; 45(4):265-72. PubMed ID: 10755313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model.
    Liu YO; Wang ZN; Chen CY; Zhuang XH; Ruan CG; Zhou Y; Cui YM
    Curr Drug Metab; 2019; 20(13):1060-1072. PubMed ID: 31755383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.
    Keller F; Czock D; Zellner D; Giehl M
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):168-75. PubMed ID: 9562234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?
    Franken LG; Masman AD; de Winter BCM; Baar FPM; Tibboel D; van Gelder T; Koch BCP; Mathot RAA
    Br J Clin Pharmacol; 2017 Aug; 83(8):1701-1712. PubMed ID: 28177137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using a semi-mechanistic model to identify the main sources of variability of metformin pharmacokinetics.
    Stage TB; Wellhagen G; Christensen MMH; Guiastrennec B; Brøsen K; Kjellsson MC
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):105-114. PubMed ID: 30267605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing.
    Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
    J Pharmacol Toxicol Methods; 2015; 72():1-10. PubMed ID: 25556117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacodynamic parameter estimation from sparse sampling: effect of sigmoidicity on parameter estimates.
    Pai SM; Girgis S; Batra VK; Girgis IG
    AAPS J; 2009 Sep; 11(3):535-40. PubMed ID: 19629711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pharmacodynamic model of respiratory rate and end-tidal carbon dioxide values during anesthesia in children.
    Lee JH; Kang PY; Jang YE; Kim EH; Kim JT; Kim HS
    Acta Pharmacol Sin; 2019 May; 40(5):642-647. PubMed ID: 30166623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adaptive designs for dose-finding studies based on sigmoid Emax model.
    Dragalin V; Hsuan F; Padmanabhan SK
    J Biopharm Stat; 2007; 17(6):1051-70. PubMed ID: 18027216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.